| 22014685 | Mol Immunol. 2011 Dec;49(3):504-11. doi: 10.1016/j.molimm.2011.09.020. Epub 2011 Oct 19.
A mutant of the major melon allergen, Cuc m 2, with reduced IgE binding capacity is a good candidate for specific immunotherapy.
Tordesillas L(1), Gamboa P, Sanz ML, Palacín A, Gómez-Casado C, Cuesta-Herranz J, Pacios LF, Salcedo G, Díaz-Perales A.
|